Skip to content

Drug interactions

Crizotinib + Elagolix

Severity: Moderate

Crizotinib and Elagolix: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak-to-moderate CYP3A4 inducer and a P-gp inhibitor, so its net effect on crizotinib is uncertain. Induction could lower crizotinib concentrations and reduce efficacy, while P-gp inhibition could raise them.

What this interaction means in plain words

Crizotinib and Elagolix can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Elagolix belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Opposing effects of CYP3A4 induction and P-gp inhibition by elagolix on crizotinib exposure.

What to do

Monitor clinical response and crizotinib adverse effects. Adjust crizotinib dosing as needed if loss of efficacy or toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Elagolix, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Elagolix?

MediHelp rates the interaction as moderate. Crizotinib and Elagolix can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix is a weak-to-moderate CYP3A4 inducer and a P-gp inhibitor, so its net effect on crizotinib is uncertain. Induction could lower crizotinib concentrations and reduce efficacy, while P-gp inhibition could raise them.

How serious is the interaction between Crizotinib and Elagolix?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response and crizotinib adverse effects. Adjust crizotinib dosing as needed if loss of efficacy or toxicity occurs.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in